Bausch Health (BHC)
(Delayed Data from NYSE)
$5.71 USD
-0.18 (-3.06%)
Updated Aug 1, 2025 03:59 PM ET
After-Market: $5.72 +0.01 (0.18%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BHC 5.71 -0.18(-3.06%)
Will BHC be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BHC based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BHC
Bausch Health Stock Falls on Q2 Earnings Miss, Revenues Beat
Bausch (BHC) Reports Q2 Earnings: What Key Metrics Have to Say
BHC: What are Zacks experts saying now?
Zacks Private Portfolio Services
Bausch Health (BHC) Lags Q2 Earnings Estimates
Why Is Bausch (BHC) Down 13% Since Last Earnings Report?
New Strong Sell Stocks for May 13th
Other News for BHC
Beyond the Balance Sheet: What SWOT Reveals About Bausch Health Companies Inc (BHC)
Bausch Health Companies Inc (BHC) Q2 2025 Earnings Call Highlights: Strong Revenue Growth Amid ...
Q2 2025 Bausch Health Companies Inc Earnings Call Transcript
Bausch Health (BHC) Reports Ninth Consecutive Quarter of Revenue Growth
Bausch Health Companies Inc. 2025 Q2 - Results - Earnings Call Presentation